We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Infectious Disease Medical Association Reviewing Eli Lilly Antibody’s EUA Data
Infectious Disease Medical Association Reviewing Eli Lilly Antibody’s EUA Data
The Infectious Diseases Society of America (IDSA) said that it is conducting its own evaluation of the data that led to the FDA’s Emergency Use Authorization (EUA) for the 700-mg dose of Eli Lilly’s COVID-19 antibody treatment bamlanivimab.